Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Self-Concept01:19

Self-Concept

1.7K
Self-concept is the cognitive and emotional understanding individuals hold about their identity. It evolves through various developmental stages, beginning in infancy and maturing as children grow. This concept influences how individuals perceive their abilities, interact with others, and manage challenges throughout life.
Infancy and Emerging Recognition
During infancy, self-concept is virtually nonexistent. Babies do not distinguish themselves as separate entities and often mistake their...
1.7K
Concepts and Prototypes01:24

Concepts and Prototypes

549
The human nervous system handles vast amounts of information by translating sensory stimuli into neural impulses, which the brain processes, creating thoughts expressed through language or stored as memories. The brain also synthesizes information from emotions and memories, which significantly influence thoughts and behaviors. This intricate process creates a comprehensive mental picture.
The brain organizes this information using concepts, which are mental categories grouping linguistic data,...
549
Formula Mass and Mole Concepts of Compounds02:56

Formula Mass and Mole Concepts of Compounds

81.3K
Formula Mass of Covalent Compounds
81.3K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.6K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.6K
Basic Concept01:28

Basic Concept

6.2K
Engineering mechanics is a branch of engineering that studies motion and the forces acting on objects. It is a fundamental subject and forms the basis of many other engineering disciplines. Length, time, mass, and force are some basic concepts in engineering mechanics.
Length, which measures the distance traveled by an object, is a fundamental concept in engineering mechanics. We use coordinates relative to a reference point to describe the distance. Length not only helps to describe the...
6.2K
Concept of Pressure at a Point01:15

Concept of Pressure at a Point

758
The concept of pressure at a point in a fluid establishes that pressure within a fluid is uniform in all directions at a specific location. This uniformity occurs because fluid molecules exert force evenly across any point due to their random motion and continuous collisions within the fluid. Pressure at a point is determined by the surrounding fluid molecules and is influenced by factors like depth and density, rather than by shape or orientation.
In a fluid at rest, pressure acts equally in...
758

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA).

Rheumatology and therapy·2026
Same author

Vasculitic fasciitis characterizes a distinct subset of vasculitic myopathy with interferon-gamma signature.

Acta neuropathologica·2025
Same author

Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study.

Rheumatology and therapy·2025
Same author

Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.

Rheumatology and therapy·2025
Same author

Myopathology and Immune Profile of Granulomatous Myositis in Sarcoid Myopathy.

Neuropathology and applied neurobiology·2025
Same author

[Diagnostics and treatment of gout : Short version of the German S3 guideline].

Zeitschrift fur Rheumatologie·2025

Related Experiment Video

Updated: Feb 1, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

10.1K

New concepts to reduce glucocorticoid toxicity.

Rieke Alten1, Max Mischkewitz1

  • 1Schlosspark-Klinik Charité University Medicine Berlin, Heubnerweg, 2, 14059 Berlin, Germany.

Joint Bone Spine
|December 12, 2018
PubMed
Summary

Low-dose glucocorticoids effectively treat rheumatoid arthritis symptoms. However, long-term use carries risks, necessitating personalized treatment plans and further research into novel therapies like modified-release prednisone.

Keywords:
GlucocorticoidsLong-term outcome Glucocorticoid Toxicity IndexModified-release prednisoneToxicityTreatment-related adverse events

More Related Videos

Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff
08:49

Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff

Published on: May 15, 2017

11.3K
Measuring RAN Peptide Toxicity in C. elegans
10:49

Measuring RAN Peptide Toxicity in C. elegans

Published on: April 30, 2020

7.1K

Related Experiment Videos

Last Updated: Feb 1, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

10.1K
Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff
08:49

Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff

Published on: May 15, 2017

11.3K
Measuring RAN Peptide Toxicity in C. elegans
10:49

Measuring RAN Peptide Toxicity in C. elegans

Published on: April 30, 2020

7.1K

Area of Science:

  • Rheumatology
  • Pharmacology
  • Clinical Medicine

Background:

  • Low-dose glucocorticoids have been used for 70 years in rheumatoid arthritis (RA) treatment.
  • They effectively reduce RA symptom severity and disease activity, especially with methotrexate.
  • Long-term glucocorticoid use is associated with adverse effects, requiring individualized treatment strategies.

Purpose of the Study:

  • To review the current role of glucocorticoids in RA management.
  • To highlight the importance of personalized therapy and risk factor assessment.
  • To introduce novel glucocorticoid formulations and delivery methods for improved RA treatment.

Main Methods:

  • Review of existing literature on glucocorticoid therapy in RA.
  • Discussion of the Glucocorticoid Toxicity Index for objective side effect measurement.
  • Exploration of emerging therapeutic concepts including modified-release prednisone, liposomal glucocorticoids, and dissociated agonists.

Main Results:

  • Modified-release prednisone shows potential for enhanced morning stiffness reduction compared to conventional prednisone, with similar efficacy and safety.
  • The Glucocorticoid Toxicity Index is crucial for future comparative studies.
  • Innovative approaches like liposomal glucocorticoids and intramuscular applications are promising but require further investigation.

Conclusions:

  • Personalized glucocorticoid therapy, considering patient risk factors, is essential for RA management.
  • Modified-release prednisone warrants further clinical trials for confirmation of benefits.
  • Future research should focus on novel glucocorticoid delivery systems and receptor modulators to optimize RA treatment and minimize toxicity.